Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Sa... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants wi... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Effica... और पढ़ें
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839533) titled 'Acupuncture as an Adjunct Treatment for Lateral Epicondylitis' on Sept. 19. Brief Summary... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy ... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with Bev... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ve... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator’s Choice of Chemotherap... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharma... और पढ़ें
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pemb... और पढ़ें